Predictive factors for visual acuity in diabetic macular oedema: lessons for clinical practice learned from deferring intravitreal injections under the COVID-19 pandemic.

چکیده

Diabetic macular oedema (DMO) is a leading cause of visual impairment globally. The COVID-19 pandemic significantly disrupted routine clinical care, including regular intravitreal therapy (IVT) for DMO. This study analysed real-world data from patients whose treatments were deferred due to the…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• رتینوپاتی دیابتی
• درمان های ضد VEGF